Cercospora sp. as a source of anti-aging polyketides targeting 26S proteasome and scale-up production in submerged bioreactor.


Journal

Journal of biotechnology
ISSN: 1873-4863
Titre abrégé: J Biotechnol
Pays: Netherlands
ID NLM: 8411927

Informations de publication

Date de publication:
10 Aug 2019
Historique:
received: 31 01 2019
revised: 14 05 2019
accepted: 27 05 2019
pubmed: 4 6 2019
medline: 18 12 2019
entrez: 2 6 2019
Statut: ppublish

Résumé

From a large screening of microbial extracts for the discovery of proteasome modulating natural products, the fungal strain Cercospora sp. (CF-223709) was selected as the most promising for further investigation. Different liquid cultures of the strain were initially screened for their anti-oxidant activity (DPPH, ABTS) and for their cytotoxicity against the A2058, HepG2 and CCD25sk cell lines. A detailed chemical analysis and evaluation of the capacity to activate 26S-proteasome was followed for the most active extract. Three main polyketides were isolated and characterized by extensive analysis of NMR and HRMS spectra data as penialidine F (1), fulvic acid (2), and SB238569 (3). Fulvic acid showed the most significant anti-oxidant activity. Its IC

Identifiants

pubmed: 31152756
pii: S0168-1656(19)30179-8
doi: 10.1016/j.jbiotec.2019.05.015
pii:
doi:

Substances chimiques

Antioxidants 0
Biological Products 0
Polyketides 0
Proteasome Endopeptidase Complex EC 3.4.25.1
ATP dependent 26S protease EC 3.4.99.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

88-96

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Katerina Georgousaki (K)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Tsafantakis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.

Sentiljana Gumeni (S)

Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.

Victor González-Menéndez (V)

Fundacion MEDINA, Granada, Spain.

Nuria de Pedro (N)

Fundacion MEDINA, Granada, Spain.

José Rubén Tormo (JR)

Fundacion MEDINA, Granada, Spain.

Celso Almeida (C)

Fundacion MEDINA, Granada, Spain.

Carole Lambert (C)

Givaudan France SAS, Active Beauty, Pomacle, France.

Olga Genilloud (O)

Fundacion MEDINA, Granada, Spain.

Ioannis P Trougakos (IP)

Department of Cell Biology and Biophysics, Faculty of Biology, National and Kapodistrian University of Athens, Athens, Greece.

Nikolas Fokialakis (N)

Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece. Electronic address: fokialakis@pharm.uoa.gr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH